posaconazol

J - Antiinfectives For Systemic Use -> J02 - Antimycotics For Systemic Use -> J02A - Antimycotics For Systemic Use -> J02AC - Triazole Derivatives -> J02AC04 - Posaconazole
Administration category: Free Medicine group: antifungal Brand name: Noxafil

Standard dosages

≥ 18 years
WeightROALoadDosage
ROA:
po
Load:
300mg
Dosage:
300mg 1 dd
ROA:
iv
Load:
300mg
Dosage:
300mg 1 dd
Comments:

iv: dag 1 oplaad 300 mg 2 dd, dag 2 e.v. 300 mg 1 dd. po tabletten: dag 1 oplaad 300 mg 2 dd, dag 2 e.v. 300 mg 1 dd. po suspensie: 400 mg 2 dd (met voedsel), 200 mg 4 dd (zonder voedsel). Tabletten hebben de voorkeur boven suspensie. Spiegelcontrole (TDM) wenselijk.

Kidney function

Renal elimination: 0%
Dosage: independent on kidney function

Renal function-replacement therapy

CAPD: aanpassing van de dosering is niet noodzakelijk

Hemo dialysis: aanpassing van de dosering is niet noodzakelijk

CAV / VVHD: aanpassing van de dosering is niet noodzakelijk

Interactions

Interaction with (ATC): Expected effect:
Interaction with (ATC):
L04AD01 - Ciclosporin
Expected effect:
spiegel ciclosporine wordt hoger
Interaction with (ATC):
L04AD02 - Tacrolimus
Expected effect:
spiegel tacrolimus wordt hoger

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-2146.5
Updated: 02/12/2020 - 22:41
Status: Published

External links
Menu position